Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study
Open accessThe DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
Background: Severe hypertriglyceridemia (HTG) is one cause of acute pancreatitis, yet the level of plasma triglycerides likely to be responsible for inducing pancreatitis has not been clearly defined. Methods and Results: A retrospective cohort study was conducted on patients presenting non-acutely to the Healthy Heart Program Lipid Clinic at St. Paul's Hospital with a TG level > 20 mM (1772 mg/dl) between 1986 and 2007. Ninety-five patients with TG > 20 mM at the time of referral were identified, in who follow up data was available for 84. Fifteen patients (15.8%), with a mean outpatient TG level of 38.1 mM, had a history of acute pancreatitis. Among 91 additional patients with less severe HTG, none had a history of pancreatitis when TG were between 10 and 20 mM. Among patients with TG > 20 mM on presentation, 8 (8.5%), with a mean TG level of 67.8 mM, exhibited eruptive xanthomata. A diet high in carbohydrates and fats (79%) and obesity (47.6%) were the two most frequent secondary causes of HTG at initial visit. By 2009, among patients with follow up data 53% exhibited either pre-diabetes or overt Type 2 diabetes mellitus. Upon referral only 23 patients (24%) were receiving a fibrate as either monotherapy or part of combination lipid-lowering therapy. Following initial assessment by a lipid specialist this rose to 84%, and remained at 67% at the last follow up visit. Conclusions: These results suggest hypertriglyceridemia is unlikely to be the primary cause of acute pancreatitis unless TG levels are > 20 mM, that dysglycemia, a diet high in carbohydrates and fats, and obesity are the main secondary causes of HTG, and that fibrates are frequently overlooked as the drug of first choice for severe HTG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, in a German cohort, 19% of those with TG >1000 mg/dL (>11.3 mmol/L) had pancreatitis.26,28”
From Clinical review on triglycerides (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Cohort studies indicate that acute pancreatitis may occur in 3% of those with TG concentrations between 10 and 20 mmol/L (885–1770 mg/dL) and 15% of those with levels >20 mmol/L (1770 mg/dL), although higher rates were reported in some selected groups.”
From Clinical review on triglycerides (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 2×
“The negative impact of metabolic syndrome, dysglycemia and abdominal obesity on triglyceride levels is well documented [1,3,11].”
BackgroundThe metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Jones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,398
Hypertriglyceridemia: its etiology, effects and treatment
Yuan, G., Al-Shali, K. Z., & Hegele, R. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060963 · Cited by 624 · cited 6×
“Insulin resistance and diabetes are associated with an increase in plasma TG for multiple reasons, including reduced insulin-dependent inhibition of lipolysis in adipocytes, increased TG and VLDL production by the liver, and impaired insulin-dependent activation of lipoprotein lipase and hydrolysis of TG-rich lipoprot…”
BackgroundInfluentialExcess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia
Johansen, C. T., Wang, J., Lanktree, M. B., Cao, H., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., et al. (2010) · Nature Genetics · doi:10.1038/ng.628 · Cited by 437 · cited 1×
“Genetic disorders leading to hypertriglyceridemia include familial combined hyperlipidemia, familial hypertriglyceridemia, remnant removal disease (Type 3 dyslipidemia), deficiencies of lipoprotein lipase or apolipoprotein CII, and more recently characterized mutations including variants of apolipoprotein A5 [4,5].”
Background(1995) · PubMed · Cited by 423
McPherson, R., Frohlich, J., Fodor, G., & Genest, J. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70310-5 · Cited by 308
Self-citationAcute Pancreatitis in a Cohort of 129 Patients Referred for Severe Hypertriglyceridemia
Lloret Linares, C., Pelletier, A. L., Czernichow, S., Vergnaud, A. C., Bonnefont-Rousselot, D., Levy, P., Ruszniewski, P., & Bruckert, E. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816074a1 · Cited by 236
(2001) · Medical Entomology and Zoology · Cited by 227
Vergès, B. L. (1999) · PubMed · Cited by 109
Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to Management
Leaf, D. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.004 · Cited by 99
Practical Applications of Fish Oil ( -3 Fatty Acids) in Primary Care
Oh, R. (2005) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.18.1.28 · Cited by 95
Cardioprotective Properties of Fibrates: Which Fibrate, Which Patients, What Mechanism?
Barter, P. J., & Rye, K. (2006) · Circulation · doi:10.1161/circulationaha.105.620450 · Cited by 68
Wang, J., Ban, M. R., Kennedy, B. A., Anand, S. S., Yusuf, S., Huff, M. W., Pollex, R. L., & Hegele, R. A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1326 · Cited by 63
Recurrent Acute and Chronic Pancreatitis in Two Brothers With Familial Chylomicronemia Syndrome
Truninger, K., Schmid, P. A., Hoffmann, M. M., Bertschinger, P., & Ammann, R. (2006) · Pancreas · doi:10.1097/01.mpa.0000202942.93578.dd · Cited by 22
DYSLIPIDAEMIA IN DIABETES MELLITUS
Vergès, B. L. (2008) · Cited by 17
Cited by
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
“26,28 However, pancreatitis risk is highest in rare patients with monogenic chylomicro-naemia, in which chylomicrons are indeed the predominant species, with low to undetectable levels of remnants and downstream lipoproteins due to severely impaired lipolytic machinery.”
BackgroundA Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Issues in Hypertriglyceridemic Pancreatitis: An Update
Scherer, J., Singh, V. P., Pitchumoni, C. S., & Yadav, D. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000436438.60145.5a · Cited by 475
Current knowledge of hypertriglyceridemic pancreatitis
Valdivielso, P., Ramírez-Bueno, A., & Ewald, N. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.08.008 · Cited by 439
“0 mmol/L as compared to 3% of those having TG 10–20 mmol/L [18].”
BackgroundChylomicronaemia–current diagnosis and future therapies
Brahm, A. J., & Hegele, R. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.26 · Cited by 356
Metadata
- Authors
- Sandhu, S., Al-Sarraf, A., Taraboanta, C., Frohlich, J., & Francis, G. A.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Francis, Gordon A
- Venue
- Lipids in Health and Disease
- Published
- 2011-09-11
- Volume
- 10
- Issue
- 1
- Pages
- 157-157
- ISSN
- 1476-511X (ISSN-L)
- PMC
- PMC3180406
- OpenAlex
- W2171747582
- Cited by
- 167
- References
- 21
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 12 · 2023: 12 · 2022: 19 · 2021: 13 · 2020: 14 · 2019: 18 · 2018: 15 · 2017: 6 · 2016: 11 · 2015: 12 · 2014: 8 · 2013: 9 · 2012: 8
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Lipids in Health and Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Open Collections
- Funders
- Canadian Institutes of Health Research (MOP-12660)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
- Keywords
- severe hypertriglyceridemia, acute pancreatitis, obesity, type 2 diabetes, prediabetes, fibrates, lipid-lowering therapy, lipid clinic patients
- MeSH terms
- Adult, Aged, Hypolipidemic Agents, British Columbia, Diabetes Mellitus, Drug Therapy, Combination, Drug Utilization, Female, Humans, Male, Middle Aged, Obesity, Pancreatitis, Practice Patterns, Physicians', Professional Competence, Retrospective Studies, Severity of Illness Index, Triglycerides, Xanthomatosis, Hypertriglyceridemia, Cohort Studies, Incidence, Fibric Acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
